Jung-Hee Kim Selected Research

cadin-2-en-1-ol-1-glucuronopyranoside

1/2012

The cadin-2-en-1β-ol-1β-D-glucuronopyranoside suppresses TPA-mediated matrix metalloproteinase-9 expression through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jung-Hee Kim Research Topics

Disease

22	Neoplasms (Cancer) 05/2022 - 10/2007
6	Infections 02/2022 - 05/2005
6	Inflammation (Inflammations) 01/2022 - 03/2010
4	Non-alcoholic Fatty Liver Disease 12/2021 - 07/2015
4	Stroke (Strokes) 08/2015 - 01/2014
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2012 - 11/2010
3	Low Back Pain (Lumbago) 07/2020 - 09/2012
3	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2009
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 01/2017
3	Body Weight (Weight, Body) 01/2017 - 01/2006
2	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 10/2017
2	Lung Neoplasms (Lung Cancer) 03/2021 - 09/2011
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2020
2	Pain (Aches) 07/2020 - 06/2017
2	Leukemia 01/2020 - 08/2002
2	Neuroblastoma 09/2018 - 01/2011
2	Acute Lung Injury 04/2016 - 05/2015
2	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2012
2	Liver Diseases (Liver Disease) 07/2015 - 07/2009
2	Adenocarcinoma 10/2014 - 01/2012
2	Breast Neoplasms (Breast Cancer) 11/2013 - 10/2010
1	Sclerosing Cholangitis 05/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 05/2022
1	COVID-19 05/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Cough 01/2022
1	Fever (Fevers) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Dementia (Dementias) 01/2021
1	Respiratory Hypersensitivity 12/2020
1	Asthma (Bronchial Asthma) 12/2020
1	Hyperthermia 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Hyperaldosteronism (Conn Syndrome) 01/2019
1	Chronic Hepatitis B 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2018
1	Necrosis 06/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2017

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 03/2021 - 05/2005
4	Therapeutic UsesIBA 01/2022 - 01/2015
4	CytokinesIBA 07/2015 - 03/2010
3	Epithelial Cell Adhesion MoleculeIBA 03/2021 - 01/2020
3	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2015
3	AntioxidantsIBA 09/2018 - 01/2012
3	Biological ProductsIBA 06/2018 - 04/2015
3	MicroRNAs (MicroRNA)IBA 03/2017 - 01/2014
3	LipopolysaccharidesIBA 04/2016 - 04/2015
2	FlavonoidsIBA 05/2022 - 02/2012
2	AntibodiesIBA 03/2021 - 09/2008
2	Monoamine Oxidase (MAO)IBA 01/2021 - 12/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2015
2	CollagenIBA 01/2019 - 10/2014
2	Ethanol (Ethyl Alcohol)IBA 09/2018 - 03/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2018 - 07/2009
2	Methanol (Carbinol)IBA 06/2018 - 04/2015
2	CateninsIBA 10/2017 - 01/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2017 - 03/2011
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2013 - 01/2012
2	naringeninIBA 02/2012 - 09/2011
2	Matrix Metalloproteinases (MMPs)IBA 01/2012 - 10/2010
2	Messenger RNA (mRNA)IBA 01/2011 - 01/2010
2	Cell Adhesion MoleculesIBA 10/2010 - 08/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 08/2002
1	kurarinoneIBA 05/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 05/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 05/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	LigandsIBA 01/2022
1	AnthraquinonesIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Arginine (L-Arginine)FDA Link 05/2021
1	Tocopherols (Tocopherol)IBA 05/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 03/2021
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2021
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 12/2020
1	Cholinesterases (Cholinesterase)IBA 12/2020
1	phorbolIBA 12/2020
1	Immunoglobulin E (IgE)IBA 12/2020
1	Interleukin-13IBA 12/2020
1	CEACAM1 ProteinIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	AldosteroneIBA 01/2019
1	ReninIBA 01/2019
1	PotassiumIBA 01/2019

Therapy/Procedure

8	Therapeutics 05/2022 - 01/2015
4	Drug Therapy (Chemotherapy) 11/2017 - 10/2007
3	Activities of Daily Living (ADL) 08/2015 - 01/2014
2	Craniotomy 08/2011 - 04/2009
1	Traditional Medicine (Folk Remedies) 01/2022
1	Oral Administration 04/2021
1	Home Nursing (Nursing, Home) 01/2021
1	Low-Level Light Therapy (LLLT) 07/2020
1	Intravenous Injections 01/2020
1	Adrenalectomy 01/2019